XML 22 R11.htm IDEA: XBRL DOCUMENT v3.25.2
Net revenues
 6 Months Ended
Jun. 29, 2025
Revenue from Contract with Customer [Abstract]  
Net revenues Net revenues
We primarily generate revenue from the sale of medical devices including single use disposable devices and, to a lesser extent, reusable devices, instruments and capital equipment. Revenue is recognized when obligations under the terms of a contract with our customer are satisfied; this occurs upon the transfer of control of the products. Generally, transfer of control to the customer occurs at the point in time when our products are shipped from the manufacturing or distribution facility. For our Original Equipment and Development Services ("OEM") product category, included within our Americas segment, most revenue is recognized over time because OEM generates revenue from the sale of custom products that have no alternative use and we have an enforceable right to payment to the extent that performance has been completed. We market and sell products through our direct sales force and distributors to customers within the following end markets: (1) hospitals and healthcare providers; (2) other medical device manufacturers; and (3) home care providers, which constituted 88%, 10% and 2% of consolidated net revenues, respectively, for the six months ended June 29, 2025. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods. With respect to the custom products sold in OEM, revenue is measured using the units produced output method. Payment is generally due 30 days from the date of invoice.
The following table disaggregates revenue by global product category for the three and six months ended June 29, 2025 and June 30, 2024.
Three Months EndedSix Months Ended
June 29, 2025June 30, 2024June 29, 2025June 30, 2024
Vascular access$185,531 $181,105 $367,898 $362,459 
Interventional
170,019 141,157 307,578 275,822 
Anesthesia96,386 102,491 182,980 198,843 
Surgical114,042 111,304 219,827 216,828 
Interventional urology76,388 83,104 147,355 162,846 
OEM78,675 88,825 142,559 176,522 
Other (1)
59,848 41,705 113,361 94,220 
Net revenues (2)
$780,889 $749,691 $1,481,558 $1,487,540 
(1)    Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products). In 2024, amounts reflect the impact from increases in our reserves related to the Italian payback measure pertaining to prior years discussed in Note 13.
(2)    The product categories listed above are presented on a global basis, as each of our reportable segments are defined based on the geographic location of its operations.